April 17, 2024 /PRNewswire/ -- Medline, a market-leading manufacturer and supplier of medical supplies and solutions, is pleased to announce that it is now a direct distributor for Epredia ...

Epredia has received 510(k) clearance from the US Food and Drug Administration (FDA) for the E1000 Dx, a digital pathology ...

Epredia Receives U.S. FDA 510(K) Clearance for the E1000 Dx™ Digital Pathology Solution Designed to Improve Laboratory Workflow in Cancer Diagnostics Innovative technology digitizes up to 1,500 ...

Please use one of the following formats to cite this article in your essay, paper or report: APA 3DHISTECH Ltd.. (2023, September 25). 3DHISTECH and Epredia open pathology innovation incubator to ...

Epredia, a global leader in precision cancer diagnostics, developed the E1000 Dx to digitize up to 1,500 tissue samples per day, enabling high-speed, automated whole-slide imaging for enhanced ...

The Epredia (anatomical pathology) business will seek to increase its market share by upgrading product quality and tapping into sales channels by region and segment used by PHC Group Business.

Spiking trade uncertainty is compounding rising debt and sluggish growth problems facing emerging markets and developing countries, but cutting their own tariffs could provide a big boost, said ...

PORTSMOUTH, N.H. & KALAMAZOO, Mich., March 04, 2025--(BUSINESS WIRE)--Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), today ...

Innovative technology digitizes up to 1,500 tissue samples daily, supporting quick and accurate diagnosis by pathologists Epredia, a global leader in precision cancer diagnostics and subsidiary of ...